⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAZZ News
Jazz Pharmaceuticals, Inc.
Form 8-K
sec.gov
JAZZ
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
prnewswire.com
JAZZ
Global Pediatric Drugs (2026-2031) - Rising Prevalence of Childhood Diseases Drives Market Growth
globenewswire.com
PFE
JNJ
GSK
SNY
NVS
PTC
BMRN
JAZZ
GILD
LLY
AMGN
AZN
MRK
ABBV
TAK
Acute Lymphoblastic Leukemia (ALL) Therapeutics Market Report 2026-2031 - Growth Sustained by Continued Clinical Innovation, Improving Pediatric Survival Outcomes and Broader MRD Adoption
globenewswire.com
AMGN
JAZZ
NVS
PFE
JNJ
GILD
MRK
ABBV
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Form 8-K
sec.gov
JAZZ
Form 8-K
sec.gov
JAZZ
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
prnewswire.com
JAZZ
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
CSL
BMRN
PFE
LNZA
TMO
MRK
CYN
INCY
GSK
JAZZ
GILD
CELU
OMER
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
PTC
BMRN
SAVA
PFE
CAT
TMO
LH
VERI
INCY
GILD
MRK
REGN
JAZZ
CELU
OMER